New dimensions in vascular engineering: Opportunities for cancer biology

Tissue Engineering - Part A

Volumn 16, Issue 7, 2010, Pages 2157-2159

  Rabbany, Sina Y ^a,b   James, Daylon ^a   Rafii, Shahin ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b HOFSTRA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; ENZYME ACTIVITY; OXYGEN; TUMORS;

ANGIOGENESIS; ANTIANGIOGENIC AGENT; CANCER BIOLOGY; CANCER THERAPEUTICS; CELL CULTURE TECHNIQUES; EXTRACELLULAR MATRIX INTERACTIONS; IN-VITRO; IN-VIVO; MICROENVIRONMENTS; NEW DIMENSIONS; OXYGEN CONCENTRATIONS; TISSUE GROWTH; TUMOR ANGIOGENESIS; TUMOR GROWTH; TUMORIGENESIS; VASCULAR ENGINEERING;

TISSUE ENGINEERING;

TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL TRANSFORMATION; CULTURE TECHNIQUE; HUMAN; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REGENERATIVE MEDICINE; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77954487893     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0183     Document Type: Article

References (13)

1. Folkman, J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285, 1182, 1971.
2. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. J Cell 86, 353, 1996.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med I, 27, 1995.
4. Bergers, G., and Benjamin, L.E. Tumorigenesis and the an-giogenic switch. Nat Rev Cancer 3, 401, 2003.
5. Butler, J., Kobayashi, H., and Rafii, S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 10, 138, 2010.
6. Carmeliet, P. Angiogenesis in health and disease. Nat Med 9, 653, 2003.
7. Yamada, K.M., and Cukierman, E. Modeling tissue morphogenesis and cancer in 3-D. Cell 130, 601, 2007.
8. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., and Mooney, D.J. Engineering tumors with 3D scaffolds. Nat Methods 4, 855, 2007.
9. Brekhman, V., and Neufeld, G. A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion. BMC Cancer 9, 415, 2009.
10. Verbridge, S.S., Choi, N.W., Zheng, Y., Brooks, D.J., Stroock, A.D., Fischbach, C. Tissue Eng 2010.
11. Yamamoto, M., James, D., Li, H., Butler, J., Rafii, S., and Rab-bany, S. Generation of stable co-cultures of vascular cells in a honeycomb alginate scaffold. Tissue Eng Part A 16, 299, 2010.
12. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergel, J.J., Marshall, V.S., and Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145, 1998.
13. James, D., Nam, H., Seandel, M., Nolan, B., Janovitz, T., Tomishima, M., Studer, L., Lee, G., Lyden, D., Benezra, R., Zaninovic, N., Rosenwaks, Z., Rabbany, S.Y., and Rafii, S. Expansion and maintenance of human vasculogenic embryonic stem cell-derived endothelial cells by TGFb inhibition is Id1 dependent. Nat Biotechnol 28, 161, 2010.